Top Banner
Friday, August 29, 2008
The Dechra Group
Blue Pointer Arnolds
Blue Pointer Dechra US
Blue Pointer Dechra PLC
Product Search


Go to advanced search

Pointer Canine Products
Pointer Equine Products
Pointer Feline Products
Pointer Large Animal Products
Information Library
Blue Pointer Cushing's Syndrome
Blue Pointer Feline Hyperthyroidism
Blue Pointer Featured Products
Blue Pointer Special Offers
Blue Pointer CPD & Show Dates
 
Cushings Syndrome Website Ad

Featured Product

Ovuplant® – for more predictable ovulation in brood mares

Ovuplant® is the latest addition to Dechra Veterinary Products’ equine pharmaceutical range.

Ovuplant is a biocompatible sustained release implant that contains the active ingredient deslorelin, a GnRH analogue.  Through the increased secretion of the luteinizing hormone (LH), Ovuplant induces precise timing of ovulation in brood mares.  It is indicated for the induction of ovulation in oestrus mares with a > 30 mm developing follicle* and studies have shown that up to 95% of mares ovulate within 36-48 hours **

Ovuplant is very easy to use. The pre-loaded implant is simply placed subcutaneously in the neck of the mare midway between head and shoulder.

As timing of ovulation can be better predicted;

  • Coverings and artificial insemination can be better planned to occur at a time that is more convenient to owners and vets.
  • There is reduced need for ultrasound and examinations
  • Fewer cross coverings are required to achieve pregnancy
  • Ovulation can be planned to take place close to the time of insemination for chilled and frozen semen

According to Giles Coley, Managing Director, Dechra Veterinary Products: “Ovuplant can save vets and their clients time and money.  As equine vets have more control over the breeding process, Ovuplant allows them to get a good night’s sleep during the breeding season.”

Developed from intellectual property held by Peptech Limited, a leading Australian biotechnology company specialising in protein and peptide research, Ovuplant is a pure synthetic implant that has shown no known adverse reactions to date.  Ovuplant is already registered and widely used in Australia, New Zealand, Canada and the United States.

* Meinert C et al. Advancing the time of ovulation in the mare with a short-term implant releasing the GnRH analogue Deslorelin. EVJ 1993, 25(1), 65-68

** Based on Peptech trial data

Click here for detailed information about Ovuplant.

 

Dechra Wedge Corner

© 2008 Dechra Veterinary Products

Dechra Ltd registered in England and Wales Reg No: 4513124. VAT Reg no: 687899532

Wedge